文献速递神经MR

颅内转移性疾病MRI特征分类框架

A Framework for MRI Characterization of Intracranial Metastatic Disease.
PubMed 文献 · Radiol Imaging Cancer · 2026-01-01

颅内转移瘤远比原发性恶性脑肿瘤常见,但研究不足,且患者常被临床试验排除;疑似软脑膜转移病患者也常因预后较差被排除。本文提出基于MRI的颅内转移瘤表现分类标准,按软脑膜转移病怀疑程度分为三类,重点在于排除软脑膜转移病,并用真实病例说明。

要点

  • MRI表现可分类为:符合软脑膜转移病(无需脑脊液确认)、不确定需进一步脑脊液或脊柱MRI评估、低度怀疑软脑膜转移病。
  • 文章提出排除软脑膜转移病的MRI标准,以减少颅内转移瘤试验中的分类变异和误判。
  • 讨论了常见陷阱、模拟病变及不确定发现的推荐下一步检查。

核心结论

  • 文章提出基于MRI的颅内转移瘤表现分类框架,按软脑膜转移病怀疑程度分为三类,重点在于排除软脑膜转移病,以减少临床试验中的分类变异和误判。

研究设计与样本

  • 本文为框架性文章,提出基于MRI的分类标准,并用真实患者示例说明;原文未报告样本量、中心数、设备或序列细节及参考标准。

关键影像表现/征象

  • 颅内转移瘤相关MRI表现分为三组:符合软脑膜转移病、不确定需进一步评估、低度怀疑软脑膜转移病。
  • 符合软脑膜转移病的影像表现无需脑脊液确认即可归类。
  • 不确定的影像发现需进一步行脑脊液分析或脊柱MRI评估。

诊断标准与关键数值

  • 分类标准基于MRI表现对软脑膜转移病的怀疑程度,分为符合软脑膜转移病、不确定、低度怀疑三组。
  • 符合软脑膜转移病的影像表现不需要脑脊液确认。
  • 不确定发现需进一步行脑脊液分析或脊柱MRI。

临床应用与阅片要点

  • 文章提出MRI分类框架用于颅内转移瘤试验中排除软脑膜转移病,并用真实病例说明。
  • 对不确定的影像发现,原文推荐进一步行脑脊液分析或脊柱MRI评估。
  • 文章讨论了常见陷阱和模拟病变,但原文未给出具体阅片建议。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Intracranial metastases (IM) are far more common than primary malignant brain tumors, yet remain understudied, representing an important unmet clinical need. Although patients with IM have historically been excluded from clinical trials, thus limiting assessment of intracranial treatment efficacy, their inclusion is increasing; however, patients with suspected leptomeningeal metastatic disease (LMD) remain commonly excluded, likely due to poorer prognosis and anticipated limited treatment response. Despite established treatment response criteria for confirmed LMD, there is limited guidance on how LMD should be diagnosed or excluded in broader IM trials, creating substantial risk for variability and misclassification. This article addresses the gap by proposing MRI-based criteria for classifying IM appearances with respect to LMD suspicion, focusing on the exclusion of LMD, illustrated with real patient examples. IM-related MRI findings are categorized into three groups: (a) imaging consistent with LMD, not requiring cerebrospinal spinal fluid confirmation; (b) equivocal findings warranting further evaluation with cerebrospinal fluid analysis or spinal MRI; and (c) imaging with low suspicion for LMD. Common pitfalls, mimics, and recommended next steps for equivocal findings are discussed. Keywords: Intracranial Metastasis, Leptomeningeal Metastatic Disease, MRI © RSNA, 2026.

来源:Radiol Imaging Cancer,查看原文。版权归原作者所有。

引用

  1. Lasocki A, Thust SC, McArthur GA, et al. A Framework for MRI Characterization of Intracranial Metastatic Disease. Radiol Imaging Cancer. 2026. PMID: 41931019. doi:10.1148/rycan.250627

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。